A detailed history of Fiduciary Trust CO transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 14,074 shares of NRIX stock, worth $279,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,074
Previous 14,074 -0.0%
Holding current value
$279,087
Previous $293,000 7.51%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$12.33 - $19.81 $41,391 - $66,502
3,357 Added 31.32%
14,074 $183,000
Q1 2022

May 12, 2022

BUY
$12.94 - $29.65 $11,063 - $25,350
855 Added 8.67%
10,717 $150,000
Q4 2021

Feb 14, 2022

BUY
$26.43 - $34.5 $84,100 - $109,779
3,182 Added 47.63%
9,862 $286,000
Q3 2021

Nov 12, 2021

BUY
$22.71 - $36.69 $151,702 - $245,089
6,680 New
6,680 $200,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.